Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters

Database
Language
Affiliation country
Publication year range
1.
Nat Immunol ; 17(8): 922-9, 2016 08.
Article in English | MEDLINE | ID: mdl-27270400

ABSTRACT

Deficiency in mevalonate kinase (MVK) causes systemic inflammation. However, the molecular mechanisms linking the mevalonate pathway to inflammation remain obscure. Geranylgeranyl pyrophosphate, a non-sterol intermediate of the mevalonate pathway, is the substrate for protein geranylgeranylation, a protein post-translational modification that is catalyzed by protein geranylgeranyl transferase I (GGTase I). Pyrin is an innate immune sensor that forms an active inflammasome in response to bacterial toxins. Mutations in MEFV (encoding human PYRIN) result in autoinflammatory familial Mediterranean fever syndrome. We found that protein geranylgeranylation enabled Toll-like receptor (TLR)-induced activation of phosphatidylinositol-3-OH kinase (PI(3)K) by promoting the interaction between the small GTPase Kras and the PI(3)K catalytic subunit p110δ. Macrophages that were deficient in GGTase I or p110δ exhibited constitutive release of interleukin 1ß that was dependent on MEFV but independent of the NLRP3, AIM2 and NLRC4 inflammasomes. In the absence of protein geranylgeranylation, compromised PI(3)K activity allows an unchecked TLR-induced inflammatory responses and constitutive activation of the Pyrin inflammasome.


Subject(s)
Alkyl and Aryl Transferases/metabolism , Familial Mediterranean Fever/metabolism , Inflammasomes/metabolism , Macrophages/physiology , Mutation/genetics , Phosphotransferases (Alcohol Group Acceptor)/metabolism , Pyrin/genetics , Alkyl and Aryl Transferases/genetics , Animals , Cells, Cultured , Familial Mediterranean Fever/genetics , Humans , Immunity, Innate , Interleukin-1beta/metabolism , Mice, Inbred C57BL , Phosphatidylinositol 3-Kinases/genetics , Phosphatidylinositol 3-Kinases/metabolism , Phosphotransferases (Alcohol Group Acceptor)/genetics , Polyisoprenyl Phosphates/metabolism , Protein Processing, Post-Translational , Signal Transduction , Toll-Like Receptors/metabolism
2.
Proc Natl Acad Sci U S A ; 115(36): 9002-9007, 2018 09 04.
Article in English | MEDLINE | ID: mdl-30127003

ABSTRACT

Alzheimer's disease (AD) is characterized by the progressive destruction and dysfunction of central neurons. AD patients commonly have unprovoked seizures compared with age-matched controls. Amyloid peptide-related inflammation is thought to be an important aspect of AD pathogenesis. We previously reported that NLRP3 inflammasome KO mice, when bred into APPswe/PS1ΔE9 (APP/PS1) mice, are completely protected from amyloid-induced AD-like disease, presumably because they cannot produce mature IL1ß or IL18. To test the role of IL18, we bred IL18KO mice with APP/PS1 mice. Surprisingly, IL18KO/APP/PS1 mice developed a lethal seizure disorder that was completely reversed by the anticonvulsant levetiracetam. IL18-deficient AD mice showed a lower threshold in chemically induced seizures and a selective increase in gene expression related to increased neuronal activity. IL18-deficient AD mice exhibited increased excitatory synaptic proteins, spine density, and basal excitatory synaptic transmission that contributed to seizure activity. This study identifies a role for IL18 in suppressing aberrant neuronal transmission in AD.


Subject(s)
Alzheimer Disease/metabolism , Amyloid/metabolism , Inflammasomes/metabolism , Interleukin-18/metabolism , Seizures/metabolism , Synaptic Transmission , Alzheimer Disease/drug therapy , Alzheimer Disease/genetics , Alzheimer Disease/pathology , Amyloid/genetics , Animals , Inflammasomes/genetics , Interleukin-18/genetics , Interleukin-1beta/genetics , Interleukin-1beta/metabolism , Levetiracetam , Mice , Mice, Knockout , NLR Family, Pyrin Domain-Containing 3 Protein/genetics , NLR Family, Pyrin Domain-Containing 3 Protein/metabolism , Piracetam/analogs & derivatives , Piracetam/pharmacology , Seizures/drug therapy , Seizures/genetics , Seizures/pathology
SELECTION OF CITATIONS
SEARCH DETAIL